Japan is the second largest pharmaceutical market in the world and leader in imports of the sector. Japanese life sciences companies are in the process of globalization and need alliances with foreign companies and biotechnology institutions to develop new medicines and incorporate new technologies. To that end, Japan is a strategic market for bioXclusters metacluster alliance. In collaboration with its Japanese Gateway Osaka Bio Headquarters, and with support of the EU-Japan Centre for industrial collaboration, bioXclusters organizes a mission to Japan in October 2017, following the 2016 success.
The organized mission allows to attend the following events.
- BioJapan (11-13 October 2017): Asia-wide benchmark trade fair for the global biotechnology industry that will bring together key business development and licensing professionals, R&D professionals and executives from biotechnology companies. This year’s fair also includes a HealthCare management and digital health area.
- European Biotech & Pharma Partnering Conference (10 October 2017): partnering conference organized by the bioXclusters plus progam in collaboration with EU-Japan Center to be held in Osaka. The meeting will feature B2B meetings with Japanese companies and it takes place at the Congrès Convention Center in Osaka, Japan.
- Regenerative Medicine Japan (11-13 October 2017): BioJapan parallel partnering event focusing on regenerative medicine.
Aforementioned European Biotech and Pharma Partnering Conference in Osaka offers business contacts to industry professionals who are looking for potential partners in the EU and Japan to ensure sustainable global business development and growth. This conference is fostered by bioXclusters “Japan Gateway” Osaka Bio Headquarters. Osaka is a well known Japanese hotspot due to its substantial pharmaceutical production power.
The brokerage event will be opened by Jun ARAI, Vice Governor, Osaka Prefectural Government and will introduce a full partnering conference. This will allow European companies to meet potential Japanese Business partners of the region.
Last year’s partnering event attracted over 60 Japanese companies and organizations from the Kansai region, which resulted in 288 pre-arranged B2B meetings between Japanese and European companies. A video of the event is still available. Meetings were successfully set-up thanks to matchmaking platform from the Enterprise Europe Network (EEN Japan).
To get an overview of some Japanese companies, which might take part in this year’s partnering conference, please see Protein Mall Kansai’s full list of member companies. From the bioXclusters alliance, 14 innovative companies will be attending.